Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06940609 · ClinicalTrials.gov registry record · Phase 2
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
A Phase 2 study of Long COVID and PASC Post Acute Sequelae of COVID 19, sponsored by University of New Mexi.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06940609 is a Phase 2 study of Long COVID and PASC Post Acute Sequelae of COVID 19 that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 60 participants, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06940609, a Phase 2 study of Long COVID and PASC Post Acute Sequelae of COVID 19, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test whether a type of rapid outpatient brain stimulation that uses magnetic fields, called accelerated intermittent theta burst stimulation (iTBS), can treat symptoms such as brain fog, depression, and anxiety in patients with Long COVID. The main questions it aims to answer are: * Is iTBS effective and feasible for reducing Long COVID symptoms? We will measure these symptoms using the Symptom Burden Questionnaire. * Are there changes in inflammatory brain chemicals associated with treatment with iTBS? We will be looking at levels of choline in the brain, which is thought to be related to inflammation. Researchers will compare sham versus active forms of iTBS to see if the active group has greater improvement in symptoms. Participants will complete symptom surveys, cognitive tests, and magnetic resonance imaging scans at the beginning, middle, and end of treatment.
Conditions Studied
Interventions
- DEVICE accelerated intermittent theta burst stimulation
Study Locations (1)
New Mexico
- University of New Mexico Health Science Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2029-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06940609
The ClinicalTrials.gov registry entry for NCT06940609 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (97% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which accelerated intermittent theta burst stimulation is the first listed.
NCT06940609 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT06940609 about?
NCT06940609 is a clinical study titled "Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation". The goal of this clinical trial is to test whether a type of rapid outpatient brain stimulation that uses magnetic fields, called accelerated intermittent theta burst stimulation (iTBS), can treat symptoms such as brain fog, depression, and anxiety in patients with Long COVID. The main questions it ...
What is the current status of trial NCT06940609?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2025-07-07. Estimated completion is 2029-06-30.
What conditions does trial NCT06940609 study?
This clinical trial studies the following conditions: Long COVID, PASC Post Acute Sequelae of COVID 19, PASC, Long COVID Syndrome, Long COVID-19 Syndrome.
What interventions are being tested in trial NCT06940609?
The interventions under investigation include: accelerated intermittent theta burst stimulation (DEVICE).
Who is sponsoring clinical trial NCT06940609?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06940609 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NE3107 in Adults With Neurological Symptoms of Long COVID
RECRUITING · Phase 2
-
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
RECRUITING · Phase 2
-
AT1001 for the Treatment of Long COVID
RECRUITING · Phase 2
-
LIFT: Life Improvement Trial
RECRUITING · Phase 2
-
A Study to Examine Anktiva for the Treatment of COVID-19.
RECRUITING · Phase 2
-
Antiviral Clinical Trial for Long Covid-19
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.